000 01577 a2200409 4500
005 20250515214436.0
264 0 _c20101202
008 201012s 0 0 eng d
022 _a1531-8257
024 7 _a10.1002/mds.23069
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJohnston, Tom H
245 0 0 _aEffect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease.
_h[electronic resource]
260 _bMovement disorders : official journal of the Movement Disorder Society
_cJul 2010
300 _a1379-90 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAkathisia, Drug-Induced
_xdrug therapy
650 0 4 _aAnimals
650 0 4 _aAntiparkinson Agents
_xadverse effects
650 0 4 _aBehavior, Animal
_xdrug effects
650 0 4 _aDisease Models, Animal
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Interactions
650 0 4 _aFamotidine
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHistamine H2 Antagonists
_xtherapeutic use
650 0 4 _aLevodopa
_xadverse effects
650 0 4 _aMPTP Poisoning
_xdrug therapy
650 0 4 _aMacaca fascicularis
650 0 4 _aMale
650 0 4 _aTime Factors
700 1 _avan der Meij, Anne
700 1 _aBrotchie, Jonathan M
700 1 _aFox, Susan H
773 0 _tMovement disorders : official journal of the Movement Disorder Society
_gvol. 25
_gno. 10
_gp. 1379-90
856 4 0 _uhttps://doi.org/10.1002/mds.23069
_zAvailable from publisher's website
999 _c19673204
_d19673204